Literature DB >> 16338017

Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design.

Mayank D Bhavsar1, Sandip B Tiwari1, Mansoor M Amiji2.   

Abstract

The tremendous progress witnessed in the field of biotechnology with respect to discovery of therapeutic and antigenic proteins has propelled the need for development of suitable oral delivery devices for these and other macromolecules. In this study, we report the encapsulation of fluorescein isothiocyanate (FITC)-labeled gelatin nanoparticles into poly(epsilon-caprolactone) (PCL) microsphere (nanoparticle-in-microsphere oral delivery system, NiMOS) by double emulsion like technique and the influence of variables such as polymer concentration in organic phase, amount of nanoparticles added as internal phase, and the speed of homogenization on particle size of NiMOS using a 3(3) randomized full factorial design. A statistical model with interaction terms was derived to predict the particle size of the hybrid system. The results from multiple linear regression analysis and Student's t-test revealed that for obtaining large particles of NiMOS, a high polymer concentration and low speed of homogenization was necessary. In contrast, to obtain particles of smaller size, high speed of homogenization was found to be very important. The mathematical model obtained was validated for prediction of particle size. The encapsulation of gelatin nanoparticles in PCL microsphere was confirmed by fluorescent microscopy. Based on the statistical model we were also successful in producing NiMOS of less than 10 mum in size, which could be used as oral delivery system for therapeutic and antigenic macromolecules.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16338017     DOI: 10.1016/j.jconrel.2005.11.001

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  25 in total

1.  Development and statistical optimization of solid lipid nanoparticles of simvastatin by using 2(3) full-factorial design.

Authors:  Mayank Shah; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2010-03-23       Impact factor: 3.246

2.  Multi-compartmental nanoparticles-in-emulsion formulation for macrophage-specific anti-inflammatory gene delivery.

Authors:  Husain Attarwala; Mansoor Amiji
Journal:  Pharm Res       Date:  2012-01-27       Impact factor: 4.200

Review 3.  miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?

Authors:  A K M Nawshad Hossian; Gerardo G Mackenzie; George Mattheolabakis
Journal:  Nanomedicine (Lond)       Date:  2019-11-18       Impact factor: 5.307

Review 4.  Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.

Authors:  Jing Xu; Shanthi Ganesh; Mansoor Amiji
Journal:  Int J Pharm       Date:  2011-05-19       Impact factor: 5.875

Review 5.  Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases.

Authors:  Davide Prosperi; Miriam Colombo; Ivan Zanoni; Francesca Granucci
Journal:  Semin Immunol       Date:  2017-08-30       Impact factor: 11.130

6.  Development of novel biodegradable polymeric nanoparticles-in-microsphere formulation for local plasmid DNA delivery in the gastrointestinal tract.

Authors:  Mayank D Bhavsar; Mansoor M Amiji
Journal:  AAPS PharmSciTech       Date:  2008-01-18       Impact factor: 3.246

7.  Modeling and optimization of degree of folate grafted on chitosan and carboxymethyl-chitosan.

Authors:  S Esfandiarpour-Boroujeni; S Bagheri-Khoulenjani; H Mirzadeh
Journal:  Prog Biomater       Date:  2015-11-19

8.  Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells.

Authors:  Padmaja Magadala; Mansoor Amiji
Journal:  AAPS J       Date:  2008-11-26       Impact factor: 4.009

9.  Nano and Microparticulate Chitosan Based System for Formulation of Carvedilol Rapid Melt Tablet.

Authors:  Ravindra Patil; Vishal Pande; Raju Sonawane
Journal:  Adv Pharm Bull       Date:  2015-06-01

10.  Development of new lipid-based paclitaxel nanoparticles using sequential simplex optimization.

Authors:  Xiaowei Dong; Cynthia A Mattingly; Michael Tseng; Moo Cho; Val R Adams; Russell J Mumper
Journal:  Eur J Pharm Biopharm       Date:  2008-12-10       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.